CompletedNCT02355028
LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration
PHASE2 · 136 planned enrolment
- Countries listed
- 1
- Registry update
- July 2, 2018
immortal.lifeTrial registrations containing the exact intervention label LHA510 vehicle.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 136 planned enrolment
PHASE1 · 110 planned enrolment